ArticleACS omega2026

Treatment with Ureidopropanamide Formyl Peptide Receptor 2 Agonists Attenuates Brain Changes Induced by Systemic Lipopolysaccharide Administration in Rats.

Kinga Tylek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.